Evidence map›Paper›PMID 29551998›Full record

ArticleFrontiers in microbiology2018

Bidirectional Regulation of AdpA

Pin Yu, Qing-Ting Bu, Yi-Li Tang, Xu-Ming Mao, Yong-Quan Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Metabolic engineering ofEngineering microbiology · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. The regulatory cascades of antibiotic production in Streptomyces.World journal of microbiology & biotechnology · 2020
    Review
  8. Article
  9. A3 foresight network on natural products.Journal of industrial microbiology & biotechnology · 2019
    Article
  10. AdpAFrontiers in microbiology · 2019
    Article
  11. Review
  12. AdpACurrent microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pin YuInstitute of Pharmaceutical Biotechnology, Zhejiang University, Hangzhou, China.
Qing-Ting BuInstitute of Pharmaceutical Biotechnology, Zhejiang University, Hangzhou, China.
Yi-Li TangInstitute of Pharmaceutical Biotechnology, Zhejiang University, Hangzhou, China.
Xu-Ming MaoInstitute of Pharmaceutical Biotechnology, Zhejiang University, Hangzhou, China.
Yong-Quan LiInstitute of Pharmaceutical Biotechnology, Zhejiang University, Hangzhou, China.
Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AdpA, an AraC/XylS family protein, had been proved as a key regulator for secondary metabolism and morphological differentiation in

Indexed as

AdpAbidirectional regulationnatamycin biosynthesispathway-specific geneStreptomyces chattanoogensis L10

Identifiers

PMID29551998
PMCPMC5840217
OpenAlexW2794060842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.